Frank C. Eisenschenk

Array ( [id] => 2980172 [patent_doc_number] => 05252711 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-10-12 [patent_title] => 'Monoclonal antibodies useful in deodorizing skin and antibody fragments thereof' [patent_app_type] => 1 [patent_app_number] => 7/766521 [patent_app_country] => US [patent_app_date] => 1991-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3303 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/252/05252711.pdf [firstpage_image] =>[orig_patent_app_number] => 766521 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3936432 [patent_doc_number] => 05981278 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-09 [patent_title] => 'Chimeric monoclonal antibodies which neutralize HIV-1 infection and their applications in therapy and prevention for AIDS' [patent_app_type] => 1 [patent_app_number] => 7/767533 [patent_app_country] => US [patent_app_date] => 1991-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 13219 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/981/05981278.pdf [firstpage_image] =>[orig_patent_app_number] => 767533 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3933550 [patent_doc_number] => 05871735 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-16 [patent_title] => 'Isoferritin as a marker for pathological pregnancy' [patent_app_type] => 1 [patent_app_number] => 7/536832 [patent_app_country] => US [patent_app_date] => 1990-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 12 [patent_no_of_words] => 10890 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/871/05871735.pdf [firstpage_image] =>[orig_patent_app_number] => 536832 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3907135 [patent_doc_number] => 05898068 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-04-27 [patent_title] => 'Monoclonal antibodies which bind mevalonate kinase' [patent_app_type] => 1 [patent_app_number] => 7/540251 [patent_app_country] => US [patent_app_date] => 1990-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7198 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/898/05898068.pdf [firstpage_image] =>[orig_patent_app_number] => 540251 [rel_patent_id] =>[rel_patent_doc_number] =>)